KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Operating Income (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Income for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Income rose 148.52% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$16.6 million, a 270.83% decrease, with the full-year FY2025 number at -$16.6 million, down 270.83% from a year prior.
  • Operating Income was $1.3 million for Q4 2025 at Biolife Solutions, up from -$89000.0 in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $90.3 million in Q4 2022 to a low of -$76.3 million in Q2 2022.
  • A 5-year average of -$3.1 million and a median of -$3.9 million in 2021 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: tumbled 10452.27% in 2021, then surged 589.29% in 2022.
  • Biolife Solutions' Operating Income stood at -$18.5 million in 2021, then soared by 589.29% to $90.3 million in 2022, then tumbled by 55.21% to $40.5 million in 2023, then crashed by 98.66% to $542000.0 in 2024, then soared by 148.52% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Operating Income are $1.3 million (Q4 2025), -$89000.0 (Q3 2025), and -$16.6 million (Q2 2025).